This report contains market size and forecasts of Tagrisso (Osimertinib) in global, including the following market information:
Global Tagrisso (Osimertinib) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tagrisso (Osimertinib) Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Tagrisso (Osimertinib) companies in 2021 (%)
The global Tagrisso (Osimertinib) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
40 mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tagrisso (Osimertinib) include AstraZeneca, Incepta Pharmaceuticals Ltd, Lonza AG, Everest Pharmaceuticals, Beacon Pharmaceuticals Limited and Drug International Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tagrisso (Osimertinib) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tagrisso (Osimertinib) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tagrisso (Osimertinib) Market Segment Percentages, by Type, 2021 (%)
40 mg
80 mg
Global Tagrisso (Osimertinib) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tagrisso (Osimertinib) Market Segment Percentages, by Application, 2021 (%)
Locally Advanced NSCLC
Metastatic NSCLC
Other
Global Tagrisso (Osimertinib) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tagrisso (Osimertinib) Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tagrisso (Osimertinib) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tagrisso (Osimertinib) revenues share in global market, 2021 (%)
Key companies Tagrisso (Osimertinib) sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Tagrisso (Osimertinib) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Incepta Pharmaceuticals Ltd
Lonza AG
Everest Pharmaceuticals
Beacon Pharmaceuticals Limited
Drug International Limited